Stiffness of the abdominal aorta in β-thalassemia major patients related with body iron load

Journal of Pediatric Hematology/Oncology

Volumn 28, Issue 10, 2006, Pages 647-652

  Ulger, Zulal ^a,b   Aydinok, Yesim ^a   Gurses, Dolunay ^a   Levent, Erturk ^a   Ozyurek, Arif R ^a  

^a EGE UNIVERSITY   (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

thalassemia major; Ferritin; Left ventricular mass index; Liver iron concentration; Stiffness of abdominal aorta

Indexed keywords

CHOLESTEROL; FERRITIN; GLUCOSE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IRON; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL AORTA; ADOLESCENT; ADULT; AGE; AORTA DISEASE; ARTERY COMPLIANCE; ARTICLE; BETA THALASSEMIA; BODY MASS; CALCULATION; CHILD; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; FERRITIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LIVER LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE PRESSURE; SEX; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; THALASSEMIA MAJOR; YOUNG MODULUS;

ADOLESCENT; ADULT; AORTA, ABDOMINAL; AORTIC DISEASES; BETA-THALASSEMIA; BLOOD PRESSURE; CHILD; ELASTICITY; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; IRON; LIVER; MALE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 33749569491     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/01.mph.0000212987.18694.5a     Document Type: Article

References (44)

1. Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and disease complications in thalassemia major. Ann N Y Acad Sci. 1998;850:227-231.
2. Lewis BS, Rachmilewitz EA, Amitai N, et al. Left ventricular function in beta-thalassemia and the effect of multiple transfusions. Am Heart J. 1978;96:636-645.
3. Livrea MA, Tesoriere L, Maggio A, et al. Oxidative modification of low-density lipoprotein and atherogenetic risk in beta-thalassemia. Blood. 1998;92:3936-3942.
4. Gillum RF. Body iron stores and atherosclerosis. Circulation. 1997;96:3261-3263.
5. Joannides R, Richard V, Haefeli WE, et al. Role of nitric oxide in the regulation of the mechanical properties of peripheral conduit arteries in humans. Hypertension. 1997;30:1465-1470.
6. Aessopos A, Samarkos M, Voskaridou E, et al. Arterial calcifications in beta-thalassemia. Angiology. 1998;49:137-143.
7. Nichols WW, O'Rourke MF. Vascular impedance. In: McDonalds's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles. 4th ed. London, UK: Edward Arnold; 1998:243-293.
8. Imura T. Non-invasive measurement of the elastic properties of the abdominal aorta and analyses of aging change-changes of elasticity of the aorta by aging. Hokkaido Igaku Zasshi. 1985;60:653-661.
9. Okubo M, Ino T, Takahashi K, et al. Age dependency of stiffness of the abdominal aorta and the mechanical properties of the aorta in Kawasaki disease in children. Pediatr Cardiol. 2001;22:198-203.
10. Levent E, Goksen D, Ozyurek AR, et al. Stiffness of the abdominal aorta in obese children. J Ped End Metab. 2002;15:405-409.
11. Lacombe F, Dart A, Dewar E, et al. Arterial elastic properties in man: a comparison of echo-Doppler indices of aortic stiffness. Eur Heart J. 1992;13:1040-1045.
12. Levent E, Ozyurek AR, Ulger Z. Evaluation of aortic stiffness in tobacco-smoking adolescents. J Adoles Health. 2004;34:339-343.
13. Sahn DJ, DeMaria A, Kisslo J, et al. The committee on M mode standardization of the American Society of Echocardiography. Results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-1083.
14. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977;55:613-618.
15. De Simone G, Daniels SR, Devereux RB, et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and the impact of overweight. J Am Coll Cardiol. 1992;20:1251-1260.
16. Stefanadis C, Stratos C, Boudoulas H, et al. Distensibility of the ascending aorta: comparison of invasive and non-invasive techniques in healthy men and in men with coronary artery disease. Eur Heart J. 1990;11:990-996.
17. Hirata K, Triposkiadis F, Sparks E, et al. The Marfan syndrome: abnormal aortic elastic properties. J Am Coll Cardiol. 1991;18:57-63.
18. Stefanadis C, Wooley CF, Bush CA, et al. Aortic distensibility abnormalities in coronary artery disease. Am J Cardiol. 1987;59:1300-1304.
19. Lage SG, Kopel L. Arterial elastic properties: comparison of results and units. J Am Coll Cardiol. 1992;20:1046-1047.
20. Cheung YF, Chan GC, Ha SY. Arterial stiffness and endothelial function in patients with beta-thalassemia major. Circulation. 2002;106:2561-2566.
21. Hiromoto M, Toma Y, Tomochika Y, et al. Echographical assessment of the early stage of experimental atherosclerosis of the descending aorta in rabbits. Jpn Circ J. 1996;60:691-698.
22. Sonesson B, Hansen F, Stale H, et al. Compliance and diameter in the human abdominal aorta - the influence of age and sex. Eur J Vasc Surg. 1993;7:690-697.
23. Blacher J, Guerin AP, Pannier B, et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99:2434-2439.
24. Tsomi K, Karagiorga-Lagana M, Fragodimitri C, et al. Arterial elastorrhexis: manifestation of a generalized elastic tissue disorder in beta-thalassaemia major. Eur J Haematol. 1999;63:287-294.
25. Aessopos A, Farmakis D, Loukopoulos D. Elastic tissue abnormalities resembling pseudoxanthoma elasticum in beta thalassemia and the sickling syndromes. Blood. 2002;99:30-35.
26. Cianciulli P, Sorrentino F, Maffei L, et al. Cardiovascular involvement in thalassemic patients with PXE-like skin lesions. A long term follow up study. Eur J Clin Invest. 2002;32:700-706.
27. Cardoso LE, Mourao PA. Compositional and structural alterations of arterial glycosaminoglycans associated with the complications brought about by thalassemia major: a case report. Angiology. 1996;47:175-183.
28. Sonakul D, Suwanagool P, Sirivaidyapong P, et al. Distribution of pulmonary thromboembolic lesions in thalassemic patients. Birth Defects Orig Artic Ser. 1987;23:375-384.
29. Borgna Pignatti C, Carnelli V, Caruso V, et al. Thromboembolic events in beta thalassemia major: an Italian multicenter study. Acta Haematol. 1998;99:76-79.
30. Aessopos A, Farmakis D. Pulmonary hypertension in beta-thalassemia. Ann N Y Acad Sci. 2005;1054:342-349.
31. Aessopos A, Farmakis D, Karagiorga M, et al. Pseudoxanthoma elasticum lesions and cardiac complications as contributing factors for strokes in beta-thalassemia patients. Stroke. 1997;28:2421-2424.
32. Pascher F, Keen R. Ulcer legs in Cooley's anemia. N Engl J Med. 1957;256:1220-1222.
33. Butthep P, Bunyaratvej A, Funahara Y, et al. Alterations in vascular endothelial cell-related plasma proteins in thalassaemic patients and their correlation with clinical symptoms. Thromb Haemost. 1995;74:1045-1049.
34. Banjerdpongchai R, Wilairat P, Fucharoen S, et al. Morphological alterations and apoptosis of endothelial cells induced by thalassemic serum in vitro. Southeast Asian J Trop Med Public Health. 1997;28:149-154.
35. Butthep P, Bunyaratvej A, Funahara Y, et al. Possible evidence of endothelial cell activation and disturbance in thalassemia: an in vitro study. Southeast Asian J Trop Med Public Health. 1997;28:141-148.
36. Aessopos A, Farmakis D, Tsironi M, et al. Endothelial function and arterial stiffness in sickle-thalassemia patients. Atherosclerosis. 2006;16. Epub ahead of print.
37. Nielsen P, Fischer R, Engelhardt R, et al. Liver iron stores in patients with secondary haemosiderosis under iron chelation therapy with deferoxamine or deferiprone. Br J Haematol. 1995;91:827-833.
38. Liu P, Olivieri N. Iron overload cardiomyopathies: new insights into an old disease. Cardiovasc Drugs Ther. 1994;8:101-110.
39. Gillum RF. Body iron stores and atherosclerosis. Circulation. 1997;96:3261-3263.
40. Sullivan JL. Iron and sex difference in heart disease. Lancet. 1981;1:1293-1294.
41. Sullivan JL. The iron paradigm of ischemic heart disease. Am Heart J. 1989;117:1177-1188.
42. Duffy SJ, Biegelsen ES, Holbrook M, et al. Iron chelation improves endothelial function in patients with coronary artery disease. Circulation. 2001;103:2799-2804.
43. Chae CU, Pfeffer MA, Glynn RJ, et al. Increased pulse pressure and risk of heart failure in the elderly. JAMA. 1999;281:634-639.
44. Panagiotakos DB, Kromhout D, Menotti A, et al. The relation between pulse pressure and cardiovascular mortality in 12,763 middle-aged men from various parts of the world: a 25-year follow-up of the seven countries study. Arch Intern Med. 2005;165:2142-2147.